Keep Up With Boomerang - Boomerang Ventures

FastCo Works: Why innovators are racing to Indiana to build their businesses

Insights

Good Reads: Why Innovators Are Racing to Indiana to Build Their Business

As the managing partner of Boomerang Ventures, an early-stage health tech venture capital fund based in Indianapolis, I find the article “Why Innovators Are Racing to Indiana to Build Their Businesses” from Fast Company very relevant. It underscores the burgeoning innovation ecosystem in the Midwest, particularly in Indiana, aligning perfectly with our focus on investing in transformative health tech companies in this region.

12/11/2023

Lydia Zeller, President & CEO, Flyte; Flyte selected as finalist in Rising Star - Women's Health, Digital Health Hub Foundation 2023 Awards

News

Flyte® Selected as Finalist in the Women’s Health Rising Star Division of the Digital Health Awards 2023

Flyte is a Boomerang Ventures’ Portfolio Company

09/22/2023

IU researchers’ quantifiable soft tissue manipulation device moves closer to helping patients

Press Releases

Indiana University Researchers’ Quantifiable Soft Tissue Manipulation Device Moves Closer to Helping Patients

BVS Muscle is a Boomerang Ventures’ Portfolio Company

08/23/2023

In The news

IU researchers’ quantifiable soft tissue manipulation device moves closer to helping patients

Source: IU Impact

IU researchers develop a quantifiable soft tissue manipulation device, moving closer to helping patients. This innovative medical device aims to improve patient outcomes through precise and effective treatments.

08/22/2023

Press Releases

Boomerang Ventures Fuels Mentavi Health’s Growth with Series AA Investment and Strategic Support

Mentavi Health is a Boomerang Ventures’ Portfolio Company

08/10/2023

In The news

US start-up secures US$2.68m to address pelvic health concerns

Source: FemTech World

US startup Pelvital secures $2.68M to address pelvic health concerns. This seed funding will support the development and market reach of their innovative medical devices designed to improve women’s health.

08/03/2023

Press Releases

Pelvital Announces $2.68 Million Seed Funding Round Led by Boomerang Ventures

Flyte is a Boomerang Ventures’ Portfolio Company

08/02/2023

In The news

Pelvital Raises $2.68M for Flyte, Its FDA-Cleared Treatment for Stress Urinary Incontinence and Weakened Pelvic Floor

Source: FemTech Insider

Pelvital raises $2.68M in seed funding to innovate pelvic health solutions. The financing will boost the development and market expansion of their advanced medical devices aimed at improving women’s health.

08/01/2023

In The news

Pelvital Raises $2.68M in Seed Funding

Source: FinSMEs

Pelvital secures $2.68M in seed funding to advance its innovative solutions for pelvic health. This investment will accelerate product development and expand market reach for their cutting-edge medical devices.

08/01/2023

In The news

ADHD Online Unveils a New Corporate Structure, Announces Series AA Investment, Establishes a New Board, and Appoints New C

Source: Yahoo! Finance

ADHD Online unveils its new corporate structure, aiming to enhance service delivery and expand its reach. This strategic move is designed to better serve patients with ADHD through innovative and accessible online healthcare solutions.

07/20/2023

BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.

Good Reads: Why Innovators Are Racing to Indiana to Build Their Business

Flyte® Selected as Finalist in the Women’s Health Rising Star Division of the Digital Health Awards 2023

Indiana University Researchers’ Quantifiable Soft Tissue Manipulation Device Moves Closer to Helping Patients

IU researchers’ quantifiable soft tissue manipulation device moves closer to helping patients

Boomerang Ventures Fuels Mentavi Health’s Growth with Series AA Investment and Strategic Support

US start-up secures US$2.68m to address pelvic health concerns

Pelvital Announces $2.68 Million Seed Funding Round Led by Boomerang Ventures

Pelvital Raises $2.68M for Flyte, Its FDA-Cleared Treatment for Stress Urinary Incontinence and Weakened Pelvic Floor

Pelvital Raises $2.68M in Seed Funding

ADHD Online Unveils a New Corporate Structure, Announces Series AA Investment, Establishes a New Board, and Appoints New C

HEADQUARTERS

CONNECT

[email protected]

[email protected]

SIGN-UP FOR BOOMERANG UPDATES